Dose-Reduced Versus Standard Conditioning Followed by Allogeneic Stem-Cell Transplantation for Patients With Myelodysplastic Syndrome

Dose-Reduced Versus Standard Conditioning Followed by Allogeneic Stem-Cell Transplantation for Patients With Myelodysplastic Syndrome: A Prospective Randomized Phase III Study of the EBMT (RICMAC Trial) – Journal of Clinical Oncology (free)

Commentaries: Reduced-Intensity vs Standard Conditioning Followed by ASCT in Myelodysplastic Syndrome – ASCO Post (free) AND Results of prospective randomized phase III study of the EBMT (Ricmac trial) dose-reduced versus standard conditioning followed by allogeneic stem cell transplantation for patients with myelodysplastic syndrome – European Society for Blood and Marrow Transplantation, via EurekAlert (free)

Source: EvidenceAlerts (free resource to find articles of interest)